CAREDX, INC. Cash and Restricted Cash
CAREDX, INC. (CDNA) had Cash and Restricted Cash of $374.16 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-30
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $374.16M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $78.47M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $65.98M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $91.99M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $374.16M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $78.47M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $65.98M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $91.99M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $68.76M 10-Q · filed 2026-07-30 |
| 2025-03-31 | $89.30M 10-Q · filed 2026-04-28 |
| 2024-12-31 | $115.27M 10-Q · filed 2026-07-30 |
| 2024-09-30 | $95.99M 10-Q · filed 2025-11-04 |
| 2024-06-30 | $96.37M 10-Q · filed 2025-08-06 |
| 2024-03-31 | $93.88M 10-Q · filed 2025-04-30 |
| 2023-12-31 | $82.78M 10-K · filed 2026-02-25 |
| 2023-09-30 | $76.56M 10-Q · filed 2024-11-04 |
| 2023-06-30 | $88.37M 10-Q · filed 2024-07-31 |
| 2023-03-31 | $75.18M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $90.44M 10-K · filed 2026-02-25 |
| 2022-09-30 | $83.16M 10-Q · filed 2023-11-08 |
| 2022-06-30 | $167.04M 10-Q · filed 2023-08-08 |
| 2022-03-31 | $172.11M 10-Q · filed 2023-05-10 |
| 2021-12-31 | $348.70M 10-K · filed 2025-02-28 |
| 2021-09-30 | $353.29M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $335.89M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $309.59M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $134.94M 10-K · filed 2024-02-28 |
| 2020-09-30 | $214.06M 10-Q · filed 2021-10-28 |
| 2020-06-30 | $211.66M 10-Q · filed 2021-07-29 |
| 2020-03-31 | $32.43M 10-Q · filed 2021-05-05 |
| 2019-12-31 | $38.48M 10-K · filed 2023-02-27 |
| 2019-09-30 | $41.18M 10-Q · filed 2020-10-29 |
| 2019-06-30 | $43.72M 10-Q · filed 2020-08-04 |
| 2019-03-31 | $57.62M 10-Q · filed 2020-04-30 |
| 2018-12-31 | $64.81M 10-K · filed 2022-02-24 |
| 2018-09-30 | $26.39M 10-Q · filed 2019-10-31 |
| 2018-06-30 | $16.42M 10-Q · filed 2019-08-01 |
| 2018-03-31 | $18.90M 10-Q · filed 2019-05-08 |
| 2017-12-31 | $26.47M 10-K · filed 2021-02-24 |
| 2017-09-30 | $15.53M 10-Q · filed 2018-11-08 |
| 2017-06-30 | $18.66M 10-Q · filed 2018-08-09 |
| 2017-03-31 | $21.74M 10-Q · filed 2018-05-10 |
| 2016-12-31 | $17.40M 10-K · filed 2020-02-28 |
| 2015-12-31 | $30.04M 10-K · filed 2019-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |